ArticleThe Journal of biological chemistry2026
Ergosterol remodeling by the MARVEL protein Mrv6 links genotoxic stress adaptation to virulence in Candida albicans.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
How fungal pathogens coordinate genotoxic stress responses with membrane homeostasis to sustain cellular signaling remains poorly understood. In this study, we characterize Mrv6, a MARVEL domain-containing membrane protein that is prominently induced by genotoxic stress. Intriguingly, rather than functioning as a canonical DNA repair factor, Mrv6 acts as a critical biophysical adjuster governing membrane lipid homeostasis. Deletion of MRV6 triggers a global transcriptional activation of the ergosterol biosynthetic pathway, resulting in aberrant cellular ergosterol accumulation. We demonstrate that this lipid imbalance fundamentally alters plasma membrane homeostasis, resulting in a less permeable architecture. Paradoxically, while this structural alteration inadvertently shields the fungus from exogenous genotoxins, conferring unexpected resistance to methyl methanesulfonate, it simultaneously hinders the intracellular transduction of environmental morphogenetic signals under hypoxic conditions. Consequently, the major hyphal repressor NRG1 remains aberrantly expressed, leading to an attenuated signaling response that significantly impairs virulence. Crucially, targeted genetic suppression of either the lipid biosynthetic node (ERG1) or the downstream signaling node (NRG1) effectively mitigates this biophysical constraint, rescuing both morphogenetic switching and pathogenicity. Collectively, our findings define a novel biochemical paradigm wherein Candida albicans utilizes a stress-responsive membrane protein to fine-tune ergosterol remodeling and membrane permeability, structurally coupling stress adaptation to signal transduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.